Hypomethylating Therapy in Patients with AML and High-Risk MDS and Chromosome 5 and 7 Abnormalities Is Associated with An Improved Outcome Compared to Conventional Chemotherapy
暂无分享,去创建一个
J. Issa | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | F. Ravandi | S. O'brien | S. Faderl | J. Shan | S. Pierce